1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of the genetic landscape of low mutation burden malignancies through multi-parallel genomic and immunologic analysis
    Meeting Abstract

    Trippett, T.; Berger, M.; Narendran, A.; Lyden, D.; Kovalchuk, O.; Bodour, S.; Laquaglia, M.; Ambati, S.; Schultz, N.; Roehrl, M.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Characterization of KDM6A loss in urothelial carcinoma
    Meeting Abstract

    Wise, H. C.; Hu, W.; Gao, P. S.; Ahmad, A.; McPherson, V. A.; Dason, S.; Pietzak, E. J.; Lyer, G.; Al-Ahmadie, H.; Solit, D. B.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Co-targeting ER and FGFR in patients with ER+/HER2- FGFR amplified (amp) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Syed, U.; Wong, S.; D'Andrea, G.; Lake, D.; Goldfarb, S.; Gajria, D.; Ligresti, L.; Rogado, A.; Reis-Filho, J.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • PLX8394 selectively disrupts BRAF-dimers and RAS-independent BRAF mutant-driven signaling
    Meeting Abstract

    Yao, Z.; Gao, Y.; Su, W.; Yaeger, R.; Na, N.; Zhang, Y.; Zhang, C.; Rymar, A.; Tao, A.; Torres, N.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • A global, randomized, placebo-controlled, phase 3 study of ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) in patients with previously untreated non-germinal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Younes, A.; Sehn, L. H.; Johnson, P.; Zinzani, P. L.; Hong, X.; Zhu, J.; Samoilova, O.; Suh, C.; Matsumura, I.; Lopez-Hernandez, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Global longitudinal strain in the SAFE-HEaRT study (Cardiac SAFEty of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function)
    Meeting Abstract

    Barac, A.; Lynce, F.; Medvedofsky, D. A.; Geng, X.; Dang, C.; Yu, A.; Tan, M.; Isaacs, C.; Swain, S. M.; Asch, F. M.
    European Heart Journal (2018)

    Fulltext@MSK | Save
  • Analysis of cell-free plasma DNA to identify tumors with microsatellite instability and exceptionally high tumor mutation burden in patients treated with PD-1 blockade
    Meeting Abstract

    Georgiadis, A.; Durham, J. N.; Keefer, L.; Bartlett, B. R.; Zielonka, M.; Murphy, D.; White, J. R.; Lu, S.; Verner, E.; Ruan, F.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Mice with a unique mutator phenotype allow detection of lymphoid leukemia tumor suppressor genes
    Meeting Abstract

    Yin, M.; Baslan, T.; Freeland, A.; Matsukawa, T.; Pruitt, S. C.; Aplan, P. D.
    Blood (2018)

    Fulltext@MSK | Save
  • A novel iPSC model reveals a role for RUNX1 in the maintenance of AML leukemia stem cells
    Meeting Abstract

    Wesely, J.; Kotini, A. G.; Georgomanoli, M.; Luo, H.; Yuan, H.; Izzo, F.; Landau, D. A.; Leslie, C.; Kharas, M. G.; Papapetrou, E. P.
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save